Select Medical Holdings Corp
SEMDelisted Jul 1, 2026- Industry
- Services-Hospitals
- SEC CIK
- 0001320414
Select Medical Holdings Corp was delisted on Jul 1, 2026; its insiders filed their last Form 4 on Jul 1, 2026; 242 institutions reported holding it in 13F filings for Q2 2026, worth $1.47B in total; no superinvestor held it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:47 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Jan 18, 2022 |
| Revenue | $5.45B | $5.19B | $6.66B | $6.33B | $6.20B |
| Selling, general and administrative | $154.4M | $225.9M | $170.2M | $153.0M | $147.0M |
| Operating income | $336.2M | $268.3M | $554.9M | $403.3M | $713.8M |
| Interest expense | – | – | $198.6M | $169.1M | $136.0M |
| Income tax | $58.2M | $44.8M | $82.6M | $62.6M | $129.8M |
| Net income | $146.2M | $214.0M | $243.5M | $159.0M | $402.2M |
| EPS, basic | $1.16 | $1.66 | $1.91 | $1.23 | $2.98 |
| EPS, diluted | $1.16 | $1.66 | $1.91 | $1.23 | $2.98 |
| Weighted shares, basic | 122.6M | 124.6M | 123.1M | 124.6M | 130.2M |
| Weighted shares, diluted | 122.6M | 124.6M | 123.1M | 124.6M | 130.2M |
| Margins and growth | |||||
| Operating margin | 6.2% | 5.2% | 8.3% | 6.4% | 11.5% |
| Net margin | 2.7% | 4.1% | 3.7% | 2.5% | 6.5% |
| Revenue growth, year over year | +5.1% | −22.2% | +5.2% | +2.1% | +12.2% |
| Net income growth, year over year | −31.7% | −12.1% | +53.1% | −60.5% | +55.3% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Jan 18, 2022 |
| Cash and equivalents | $26.5M | $59.7M | $84.0M | $97.9M | $74.3M |
| Accounts receivable | $864.2M | $821.4M | $940.3M | $941.3M | $889.3M |
| Total current assets | $1.03B | $1.02B | $1.26B | $1.27B | $1.14B |
| Property, plant and equipment | – | – | $1.02B | $1.00B | $961.5M |
| Goodwill | $2.36B | $2.33B | $3.51B | $3.48B | $3.45B |
| Intangible assets | $100.8M | $103.2M | $329.9M | $351.7M | $374.9M |
| Total assets | $5.85B | $5.61B | $7.69B | $7.67B | $7.36B |
| Accounts payable | $157.1M | $142.2M | $174.3M | $186.7M | $233.8M |
| Total current liabilities | $984.5M | $977.7M | $1.25B | $1.16B | $1.27B |
| Total liabilities | $3.82B | $3.61B | $6.12B | $6.27B | $6.00B |
| Shareholders' equity | $2.02B | $1.99B | $1.55B | $1.36B | $1.33B |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 10-K | 10-K | 10-K | 10-K | 10-K |
| Reported | Feb 19, 2026 | Feb 20, 2025 | Feb 22, 2024 | Feb 23, 2023 | Jan 18, 2022 |
| Operating cash flow | $346.5M | $517.9M | $582.1M | $284.8M | $401.2M |
| Capital expenditures | $229.2M | $222.2M | $229.2M | $190.4M | $180.5M |
| Free cash flow | $117.2M | $295.7M | $352.9M | $94.5M | $220.7M |
| Depreciation and amortization | $140.3M | $203.9M | $208.7M | $205.8M | $202.6M |
| Stock-based compensation | $16.7M | $100.7M | $43.8M | $37.8M | $30.9M |
| Dividends paid | $31.4M | $64.6M | $63.9M | $64.6M | $50.6M |
| Investing cash flow | -$216.5M | -$231.0M | -$268.5M | -$226.3M | -$256.6M |
| Financing cash flow | -$163.2M | -$311.2M | -$327.5M | -$34.9M | -$647.4M |
| Net change in cash | -$33.2M | -$24.3M | -$13.9M | $23.6M | -$502.8M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 0.3% | 1.9% | 0.7% | 0.6% | 0.5% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Mar 31, 2026 | 124.0M | −3.5% | SEC |
| Feb 1, 2026 | 124.0M | −3.8% | SEC |
| Sep 30, 2025 | 123.8M | −4.4% | SEC |
| Jul 31, 2025 | 124.0M | −4.6% | SEC |
| Apr 30, 2025 | 128.5M | −1.1% | SEC |
| Feb 1, 2025 | 129.0M | +0.5% | SEC |
| Oct 31, 2024 | 129.5M | +1.0% | SEC |
| Jul 31, 2024 | 130.0M | +2.3% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.